Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The EIR was issued following an inspection of the facility conducted from June 10 to June 13, 2024
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Revolutionary technology will further boost OneSource’s scientific services offerings
Subscribe To Our Newsletter & Stay Updated
